AbbVie
The Associate Scientific Director, Oncology Early Development oversees the design, execution, and interpretation of early-phase clinical trials, ensuring alignment with product development plans and regulatory standards. The role collaborates cross‑functionally with discovery, medical affairs, and commercial teams to generate high‑quality data supporting the oncology pipeline.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
Clinical Scientist Director – Early Development, Oncology
Amgen
Scientific Director, Oncology Clinical Development - Lung
AbbVie
Global Development Medical Director Hematology Oncology Gaithersburg Maryland United States Of America
AstraZeneca
Director, Clinical Science – Oncology Clinical Development
GSK plc
Senior Medical Director, Oncology Clinical Development - GU
GSK plc
Global Development Medical Director, Hematology
AstraZeneca